Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2010
07/01/2010WO2010075080A1 A method of treating insomnia
07/01/2010WO2010075074A1 Protein kinase inhibitors
07/01/2010WO2010075069A1 Bicyclic pyranone derivatives as nicotinic acid receptor agonists
07/01/2010WO2010075064A1 Triple reuptake inhibitors and methods of their use
07/01/2010WO2010075060A2 Methods and compositions for modulating proline levels
07/01/2010WO2010075045A1 Salvinorin derivatives and uses thereof
07/01/2010WO2010075037A1 Systems and methods for enhancing vaccine efficacy
07/01/2010WO2010075026A2 Methods for determining efficacy of a therapeutic regimen against deleterious effects of cytotoxic agents in human
07/01/2010WO2010074961A1 Compositions of topical ocular solutions to deliver effective concentrations of active agent to the posterior segment of the eye
07/01/2010WO2010074949A1 Apparatus and methods for containing and delivering therapeutic agents
07/01/2010WO2010074947A1 Amino pyrazole compound
07/01/2010WO2010074940A1 Compositions and nutritional supplements for improving ocular health and reducing ocular inflammatory response
07/01/2010WO2010074936A2 Enzastaurin for the treatment of cancer
07/01/2010WO2010074807A1 3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators
07/01/2010WO2010074783A1 Phosphodiesterase inhibitors and uses thereof
07/01/2010WO2010074776A2 Compounds for the treatment of cancer
07/01/2010WO2010074746A1 Methods of use for opsin binding ligands
07/01/2010WO2010074724A1 Combination of aurora kinase inhibitors and anti-cd20 antibodies
07/01/2010WO2010074662A1 Antitumor agent, a method for the production of said agent and a method for the stabilisation thereof
07/01/2010WO2010074647A1 Ethanamine compounds and their use for treating depression
07/01/2010WO2010074607A2 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
07/01/2010WO2010074591A1 Creatine amides, a method for the production thereof and an agent exhibiting a neuroprotective action
07/01/2010WO2010074587A2 5-o-substituted 3-n-aryl-1,3,4-oxadiazolones for medical use
07/01/2010WO2010074586A1 Pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine derivatives and their use in cancer therapy
07/01/2010WO2010074540A2 Pharmaceutical composition containing an anionic drug, and a production method therefor
07/01/2010WO2010074480A2 Novel pyrazolodiazepine compounds as a transglutaminase inhibitor, the preparation method thereof and a composition containing the same
07/01/2010WO2010074460A2 Novel pharmaceutical composition for ameliorating side effects of a lipase inhibitor
07/01/2010WO2010074361A1 Phytoestrogenic compositions for preventing or treating symptoms associated with menopause
07/01/2010WO2010074284A1 Pyrazolopyrimidine compound
07/01/2010WO2010074271A1 Therapeutic agent for diabetes
07/01/2010WO2010074244A1 Isoquinoline derivative
07/01/2010WO2010074241A1 Method for predicting therapeutic effect of combination chemotherapy
07/01/2010WO2010074240A1 Method for predicting therapeutic effect of chemotherapy
07/01/2010WO2010074220A1 Composition containing sesamins and epigallocatechin gallate
07/01/2010WO2010074219A1 Benzothiophen compound
07/01/2010WO2010074193A1 Novel bicyclic heterocyclic compound
07/01/2010WO2010074183A1 Transdermal preparation
07/01/2010WO2010074182A1 Transdermal preparation
07/01/2010WO2010074113A1 Dry powder pharmaceutical composition for inhalation
07/01/2010WO2010074110A1 Method for producing cyclic aminobenzoic acid derivative
07/01/2010WO2010074090A1 Crystals of hydrochloride of pyridazin-3(2h)-one compound and process for production of same
07/01/2010WO2010074089A1 Indanyl compounds
07/01/2010WO2010074088A1 Cyclic amine compounds
07/01/2010WO2010074052A1 Melanin production inhibitor
07/01/2010WO2010073825A1 Antibacterial composition and antiviral composition each containing silicon-containing compound, antibacterializing method, cleaning/mouth cleaning method, and method for immobilizing antibacterial agent or antiviral agent
07/01/2010WO2010073721A1 Prediction of effectiveness of preoperative chemoradiotherapy on rectal cancer using micro-rna
07/01/2010WO2010073719A1 Eg5 inhibitor
07/01/2010WO2010073667A1 Ultraviolet rays protective agent
07/01/2010WO2010073642A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
07/01/2010WO2010073404A1 Proanthocyanidine of cashew apple, proanthocyanidine-containing composition and use of the same
07/01/2010WO2010073326A1 Percutaneous absorption preparation
07/01/2010WO2010073266A1 Sequence variants predictive of risk of kidney stones and bone mineral density
07/01/2010WO2010073258A1 Bicyclic triterpenoid iripallidal as a novel antiglioma and antineoplastic therapy in vitro
07/01/2010WO2010073255A1 Process for preparing ziprasidone
07/01/2010WO2010073254A2 Process for preparing efavirenz polymorph
07/01/2010WO2010073235A1 Ppar agonist compositions and methods of use
07/01/2010WO2010073173A1 Maintenance fluid for animals
07/01/2010WO2010073126A2 Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof
07/01/2010WO2010073124A2 Processes for preparing highly pure rotigotine or a pharmaceutically acceptable salt thereof
07/01/2010WO2010073104A2 Improving cognitive function
07/01/2010WO2010073034A1 Pyrimidine indole derivatives for treating cancer
07/01/2010WO2010073011A2 Compounds useful as medicaments
07/01/2010WO2010072950A1 Formulation for delivering lipid-lowering drugs by oral transmucosal administration
07/01/2010WO2010072930A1 Novel method for the synthesis of ivabradine
07/01/2010WO2010072844A1 Implantable devices for treating hiv
07/01/2010WO2010072829A1 Selective histamine h4 receptor antagonists for the treatment of vestibular disorders.
07/01/2010WO2010072823A1 PYRAZOLE[1,5a]PYRIDINE DERIVATIVES
07/01/2010WO2010072813A1 Competitive inhibitors of type ii dehydroquinase enzyme
07/01/2010WO2010072807A2 Inhibitors of cystathionine beta synthase to reduce the neurotoxic overproduction of endogenous hydrogen sulfide
07/01/2010WO2010072774A2 Agent for treating stenosis of the spinal canal
07/01/2010WO2010072770A2 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
07/01/2010WO2010072754A1 HYDROSOLUBLE [6)O-α-D-GLCP-(1→]n-6-O-β-D-GLCP-(1→-PHENOLIC DERIVATIVES WITH DERMOCOSMETIC, NUTRITIONAL AND THERAPEUTIC APPLICATIONS, AND COMPOSITIONS CONTAINING SAID WATER SOLUBLE COMPOUNDS
07/01/2010WO2010072743A1 Immunostimulating saponins for use in in situ tumor-destruction therapy
07/01/2010WO2010072738A1 Polyunsaturated fatty acid and diol ester as an anti-acne agent
07/01/2010WO2010072734A2 Targeting prodrugs and compositions for the treatment of gastrointestinal diseases
07/01/2010WO2010072722A1 Piperidine derivatives useful as orexin antagonists
07/01/2010WO2010072712A1 Biaryl benzylamine derivatives
07/01/2010WO2010072703A1 Dosage regimen of an s1p receptor agonist
07/01/2010WO2010072672A1 New crystal polymorphs of ceftobiprole
07/01/2010WO2010072610A1 One-step process for preparing paliperidone and its oxalate salt
07/01/2010WO2010072607A1 Dihydropyridone amides as p2x7 modulators
07/01/2010WO2010072605A1 Dihydropyridone amides as p2x7 modulators
07/01/2010WO2010072599A1 Dihydropyridone ureas as p2x7 modulators
07/01/2010WO2010072598A1 Heterocyclic antiviral compounds
07/01/2010WO2010072597A1 Dihydropyridone amides as p2x7 modulators
07/01/2010WO2010072420A2 Compositions comprising hemp oil for treating topical diseases, especially hand-foot syndrome
07/01/2010WO2010072401A1 Low dose controlled release tablet
07/01/2010WO2010072399A1 7-azaindirubins, 7'azaindirubins, 7,7'-diazaindirubins and the corresponding 3'-oxime ether derivatives thereof, their production and use as a medicament
07/01/2010WO2010072398A2 Veterinary formulations
07/01/2010WO2010072354A1 MESYLATE SALT OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO }-1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR
07/01/2010WO2010072353A1 Liquid pharmaceutical compositions comprising a triptan compound and xylitol
07/01/2010WO2010072352A1 1, 2, 4 -oxadiazole derivatives and their therapeutic use
07/01/2010WO2010072338A1 Alkaloid aminoester derivatives and medicinal composition thereof
07/01/2010WO2010072315A1 Amino acid ester prodrugs and the use thereof
07/01/2010WO2010072314A1 Dipeptoid prodrugs and the use thereof
07/01/2010WO2010072301A1 3-(3-pyrimidine-2-yl-benzyl)-[1,2,4] triazolo [4,3-b] pyridazine derivatives
07/01/2010WO2010072296A1 Pyridazinone derivatives
07/01/2010WO2010072295A1 Novel polymorphic forms of 6-(1-methyl-1h-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2h-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof
07/01/2010WO2010072277A1 Local anesthetic for relieving breast pain
07/01/2010WO2010072183A2 Beer and beer-based beverages and method of modification of polyphenols and silicon content in these beverages
1 ... 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 2202 2203 2204 2205 2206 2207 2208 2209 2210 2211 ... 7860